Fmoc-Leu-OH

Modify Date: 2025-08-21 18:20:07

Fmoc-Leu-OH Structure
Fmoc-Leu-OH structure
Common Name Fmoc-Leu-OH
CAS Number 35661-60-0 Molecular Weight 353.412
Density 1.2±0.1 g/cm3 Boiling Point 559.8±33.0 °C at 760 mmHg
Molecular Formula C21H23NO4 Melting Point 152-156 °C(lit.)
MSDS Chinese USA Flash Point 292.4±25.4 °C

 Use of Fmoc-Leu-OH


Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity[1].

 Names

Name (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid
Synonym More Synonyms

 Fmoc-Leu-OH Biological Activity

Description Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity[1].
Related Catalog
Target

PPARγ

References

[1]. Rocchi S, et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell. 2001 Oct;8(4):737-47.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 559.8±33.0 °C at 760 mmHg
Melting Point 152-156 °C(lit.)
Molecular Formula C21H23NO4
Molecular Weight 353.412
Flash Point 292.4±25.4 °C
Exact Mass 353.162720
PSA 75.63000
LogP 4.95
Vapour Pressure 0.0±1.6 mmHg at 25°C
Index of Refraction 1.583
Storage condition 2~8°C

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xi
Risk Phrases R36/37/38
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2924299090

 Synthetic Route

 Customs

HS Code 2924299090
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles8

More Articles
Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.

Cancer Sci. 106 , 747-56, (2015)

L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherap...

Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.

PLoS ONE 10 , e0126910, (2015)

Cardiovascular disease (CVD) is a serious comorbidity in nonalcoholic fatty liver disease (NAFLD). Since plasma ceramides are increased in NAFLD and sphingomyelin, a ceramide metabolite, is an indepen...

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.

Sci. Rep. 4 , 6777, (2014)

Amyloid-β (Aβ) is one of the few neuropathological biomarkers associated with transporters of the blood-brain barrier (BBB). Despite the well-characterized clinical indication of decreasing Aβ levels ...

 Synonyms

D-LeuFmoc-OH
Fmoc-Leu-OH
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-leucine
EINECS 252-662-7
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid
MFCD00037133
Tocris-0675
FMOC-D-LEU
Fmoc-D-Leu-OH
Fmoc-L-leucine
Fmoc-L-Leu-OH
L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-leucine
Fmoc-D-leucine-OH
N-Fmoc-D-leucine
D-Fmoc-Leu-OH
N-Fmoc-L-leucine
D-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
Fmoc-D-Leucine
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here







Get all suppliers and price by the below link:

Fmoc-Leu-OH suppliers


Price: ¥30/5g

Reference only. check more Fmoc-Leu-OH price